ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BIIB Biogen Inc

208.50
6.04 (2.98%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Biogen Inc BIIB 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
6.04 2.98% 208.50 08:47:07
개장가 저가 고가 종가 전일 종가
201.22 199.10 210.83 208.90 202.46
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/04/202408:30PRNUSEisai Completes Submission of LEQEMBI® (lecanemab-irmb)..
06/03/202421:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
05/03/202406:15GLOBEBiogen Highlights New Data at the International Conference..
27/02/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202421:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
23/02/202400:12EDGAR2Form 144 - Report of proposed sale of securities
22/02/202411:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202411:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202400:24EDGAR2Form 144 - Report of proposed sale of securities
21/02/202411:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202408:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202408:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202408:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202421:07EDGAR2Form 8-K - Current report
13/02/202409:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202409:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202406:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
13/02/202401:10EDGAR2Form 144 - Report of proposed sale of securities
10/02/202410:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202410:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202410:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202410:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202410:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202410:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202410:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202410:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202409:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202409:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202400:44EDGAR2Form 144 - Report of proposed sale of securities
01/02/202407:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202407:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/01/202404:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/12/202321:30GLOBECentralized Marketing Authorizations of Generic Versions of..
15/12/202323:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202320:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..

최근 히스토리

Delayed Upgrade Clock